Index RUT
P/E 15.87
EPS (ttm) 0.46
Insider Own 23.12%
Shs Outstand 146.23M
Perf Week 17.54%
Market Cap 1.09B
Forward P/E 17.76
EPS next Y 0.41
Insider Trans -0.23%
Shs Float 113.48M
Perf Month 4.99%
Income 67.40M
PEG 1.06
EPS next Q 0.08
Inst Own 41.34%
Short Float 4.85%
Perf Quarter -5.15%
Sales 334.51M
P/S 3.25
EPS this Y -15.32%
Inst Trans 3.12%
Short Ratio 6.32
Perf Half Y 14.26%
Book/sh 1.06
P/B 6.98
EPS next Y 32.45%
ROA 35.95%
Short Interest 5.51M
Perf Year 38.79%
Cash/sh 0.33
P/C 22.43
EPS next 5Y 15.00%
ROE 60.87%
52W Range 4.47 - 9.27
Perf YTD -15.96%
Dividend Est. -
P/FCF 32.77
EPS past 5Y -
ROI 38.70%
52W High -20.50%
Beta 1.89
Dividend TTM -
Quick Ratio 2.71
Sales past 5Y -1.19%
Gross Margin 83.27%
52W Low 64.69%
ATR (14) 0.33
Dividend Ex-Date -
Current Ratio 3.29
EPS Y/Y TTM 299.53%
Oper. Margin 13.69%
RSI (14) 60.13
Volatility 6.49% 4.37%
Employees 895
Debt/Eq 0.12
Sales Y/Y TTM 19.20%
Profit Margin 20.15%
Recom 1.00
Target Price 12.67
Option/Short Yes / Yes
LT Debt/Eq 0.12
EPS Q/Q 205.83%
Payout 0.00%
Rel Volume 0.95
Prev Close 7.50
Sales Surprise 6.79%
EPS Surprise 33.33%
Sales Q/Q 18.18%
Earnings Apr 30 AMC
Avg Volume 872.01K
Price 7.37
SMA20 12.58%
SMA50 -0.04%
SMA200 -2.12%
Trades
Volume 832,074
Change -1.73%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-07-24 Initiated
Lake Street
Buy
$12
Oct-27-23 Initiated
Craig Hallum
Buy
$12
Oct-13-22 Initiated
Mizuho
Buy
$7
Jul-26-21 Initiated
Northland Capital
Outperform
$23
Mar-19-21 Initiated
H.C. Wainwright
Buy
$20
May-02-24 04:10PM
May-01-24 09:33AM
(Thomson Reuters StreetEvents) +18.67%
03:30AM
Apr-30-24 08:55PM
04:13PM
(Associated Press Finance)
04:01PM
Loading…
04:01PM
Apr-16-24 08:00AM
Apr-01-24 04:37PM
Mar-27-24 08:00AM
Mar-20-24 07:00AM
Mar-13-24 08:00AM
Mar-04-24 08:00AM
Feb-29-24 10:49AM
Feb-28-24 04:55PM
04:41PM
(Associated Press Finance)
04:01PM
Loading…
04:01PM
Feb-21-24 11:51PM
Feb-20-24 08:00AM
Feb-13-24 12:58PM
Feb-12-24 08:00AM
Jan-22-24 08:00AM
Jan-17-24 10:25AM
Dec-29-23 05:12PM
05:00PM
Dec-28-23 08:00AM
Nov-13-23 08:00AM
Nov-02-23 08:00AM
Oct-31-23 09:09AM
07:28AM
(Thomson Reuters StreetEvents)
06:50AM
06:03PM
Loading…
Oct-30-23 06:03PM
04:50PM
(Associated Press Finance)
04:01PM
Oct-27-23 10:01AM
Oct-16-23 08:00AM
Sep-26-23 08:00AM
Sep-05-23 08:00AM
Aug-15-23 04:01PM
Aug-08-23 02:05PM
Aug-02-23 08:53AM
(Thomson Reuters StreetEvents)
06:36AM
Aug-01-23 04:07PM
(Associated Press Finance)
04:01PM
Jul-26-23 01:30PM
Jul-18-23 08:00AM
Jul-11-23 08:30AM
Jul-05-23 08:00AM
Jul-03-23 03:59AM
Jun-27-23 06:46AM
Jun-22-23 11:13AM
(Zacks Small Cap Research)
Jun-20-23 04:01PM
May-25-23 01:29PM
May-03-23 09:22AM
(Thomson Reuters StreetEvents) +39.37%
07:21AM
(Zacks Small Cap Research)
May-02-23 04:17PM
04:01PM
Apr-18-23 08:00AM
Apr-13-23 08:29AM
Mar-23-23 04:01PM
Mar-16-23 08:00AM
Mar-03-23 11:17AM
05:17AM
Mar-01-23 11:22AM
(Simply Wall St.) -12.99%
10:13AM
(Thomson Reuters StreetEvents)
04:21AM
(Zacks Small Cap Research)
Feb-28-23 04:01PM
Feb-15-23 08:00AM
Jan-31-23 05:38AM
(Zacks Small Cap Research)
Jan-30-23 08:00AM
Jan-09-23 08:02AM
Jan-04-23 04:01PM
Jan-03-23 08:00AM
Dec-08-22 08:00AM
Nov-10-22 08:00AM
Nov-03-22 06:32AM
(Zacks Small Cap Research) +5.43%
Nov-02-22 04:15PM
08:03AM
Oct-19-22 08:00AM
Oct-04-22 08:00AM
Sep-23-22 11:18AM
(Zacks Small Cap Research)
Sep-22-22 10:10AM
Sep-20-22 08:00AM
Sep-19-22 07:00AM
Sep-12-22 04:30PM
12:59PM
(American City Business Journals)
05:13AM
(Zacks Small Cap Research)
Sep-06-22 07:00AM
Aug-26-22 09:00AM
Aug-04-22 04:07PM
05:30AM
(Zacks Small Cap Research)
Aug-02-22 04:05PM
Jul-27-22 08:00AM
Jul-24-22 10:38AM
Jul-20-22 08:00AM
Jul-18-22 09:35AM
Jun-15-22 08:30AM
Jun-14-22 05:16PM
Jun-07-22 04:05PM
02:42PM
Jun-03-22 08:00AM
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hulse William Frank IV General Counsel and CAO Mar 13 '24 Sale 7.95 20,381 162,029 479,959 Mar 15 06:35 PM Whitlow Ricci S Chief Operating Officer Feb 20 '24 Sale 8.01 15,271 122,351 401,050 Feb 21 04:40 PM Whitlow Ricci S Chief Operating Officer Feb 16 '24 Sale 8.07 15,493 125,075 416,321 Feb 21 04:40 PM Whitlow Ricci S Chief Operating Officer Feb 15 '24 Sale 8.06 15,198 122,496 431,814 Feb 16 04:22 PM Whitlow Ricci S Chief Operating Officer Feb 14 '24 Sale 8.03 15,845 127,267 447,012 Feb 16 04:22 PM DOUG RICE Chief Financial Officer Nov 21 '23 Buy 7.16 5,000 35,786 102,200 Nov 22 05:01 PM Stein Robert Benjamin President, Regenerative Med. May 16 '23 Sale 5.95 10,365 61,627 317,803 May 17 06:26 PM Stein Robert Benjamin President, Regenerative Med. May 15 '23 Sale 6.15 3,607 22,170 328,168 May 17 06:26 PM Carlson Peter M Chief Financial Officer May 10 '23 Sale 5.93 5,976 35,414 656,435 May 12 06:50 PM Hulse William Frank IV General Counsel and CAO May 10 '23 Sale 5.93 5,870 34,786 456,564 May 12 06:58 PM Stein Robert Benjamin President, Regenerative Med. May 10 '23 Sale 5.93 5,869 34,780 331,775 May 12 06:56 PM Phelan William Lawrence Chief Accounting Officer May 10 '23 Sale 5.93 1,595 9,452 184,219 May 12 06:53 PM
Index -
P/E 9.15
EPS (ttm) 197.01
Insider Own 3.00%
Shs Outstand 2.56M
Perf Week 1.93%
Market Cap 4.61B
Forward P/E 30.04
EPS next Y 60.00
Insider Trans 1.32%
Shs Float 2.48M
Perf Month 3.64%
Income 502.30M
PEG -
EPS next Q 105.00
Inst Own 89.44%
Short Float 1.49%
Perf Quarter 12.70%
Sales 2.17B
P/S 2.13
EPS this Y -24.47%
Inst Trans -14.01%
Short Ratio 4.45
Perf Half Y 23.76%
Book/sh 1656.15
P/B 1.09
EPS next Y -60.00%
ROA 6.82%
Short Interest 0.04M
Perf Year 24.38%
Cash/sh -
P/C -
EPS next 5Y -7.70%
ROE 12.58%
52W Range 1319.05 - 1855.00
Perf YTD 19.77%
Dividend Est. -
P/FCF 8.86
EPS past 5Y -
ROI 10.44%
52W High -2.83%
Beta 0.45
Dividend TTM 1.00 (0.06%)
Quick Ratio -
Sales past 5Y 60.37%
Gross Margin -
52W Low 36.66%
ATR (14) 31.54
Dividend Ex-Date Mar 08, 2024
Current Ratio 1.87
EPS Y/Y TTM 682.71%
Oper. Margin 31.24%
RSI (14) 57.10
Volatility 1.10% 1.18%
Employees 782
Debt/Eq 0.14
Sales Y/Y TTM 73.84%
Profit Margin 23.18%
Recom -
Target Price -
Option/Short No / Yes
LT Debt/Eq 0.13
EPS Q/Q 611.00%
Payout 0.50%
Rel Volume 1.60
Prev Close 1825.00
Sales Surprise -
EPS Surprise -1.11%
Sales Q/Q 68.37%
Earnings Feb 07 BMO
Avg Volume 8.29K
Price 1802.57
SMA20 2.93%
SMA50 2.31%
SMA200 13.11%
Trades
Volume 13,282
Change -1.23%
Apr-11-24 06:10AM
Apr-10-24 08:00AM
Feb-23-24 08:00AM
08:00AM
Feb-12-24 08:00AM
03:16AM
Loading…
Feb-08-24 03:16AM
Feb-07-24 08:34AM
08:23AM
(Associated Press Finance)
08:00AM
Jan-23-24 04:16AM
Dec-24-23 10:30AM
Dec-21-23 04:15PM
Dec-13-23 09:00AM
Nov-21-23 03:13PM
Nov-20-23 03:03PM
09:06AM
Loading…
Nov-06-23 09:06AM
08:19AM
(Associated Press Finance)
08:00AM
Oct-25-23 08:00AM
Oct-20-23 08:00AM
Aug-10-23 09:51AM
Aug-07-23 08:24AM
(Associated Press Finance)
08:00AM
Jul-25-23 06:00AM
Jul-03-23 05:41AM
Jun-30-23 08:00AM
Jun-27-23 08:00AM
Jun-24-23 03:27PM
Jun-21-23 09:21AM
May-26-23 06:15AM
04:15PM
Loading…
May-25-23 04:15PM
May-22-23 08:00AM
May-09-23 08:27AM
08:00AM
Apr-17-23 02:14PM
Mar-20-23 06:30AM
Mar-15-23 03:19PM
Feb-09-23 08:37AM
Feb-07-23 08:00AM
Feb-06-23 07:50AM
Dec-21-22 08:15AM
Nov-07-22 08:00AM
Oct-12-22 02:02PM
Oct-07-22 03:15PM
Sep-26-22 08:00AM
Sep-21-22 08:14AM
03:53AM
Sep-06-22 09:00AM
Aug-22-22 06:00AM
Aug-08-22 08:00AM
Jul-28-22 01:27PM
Jun-14-22 09:00AM
Jun-09-22 12:00PM
May-26-22 08:00AM
May-24-22 08:00AM
May-10-22 10:42AM
May-09-22 09:42AM
09:13AM
09:10AM
May-06-22 08:00AM
May-05-22 01:18PM
Mar-31-22 06:29PM
Feb-08-22 01:38PM
Jan-10-22 09:15AM
Dec-16-21 11:51AM
Dec-11-21 12:38AM
Dec-08-21 04:38PM
Dec-02-21 04:05PM
Nov-23-21 12:41PM
Nov-16-21 09:00AM
Nov-08-21 08:00AM
Oct-12-21 02:47PM
08:00AM
Sep-15-21 09:00AM
Sep-09-21 01:00PM
Aug-06-21 08:00AM
Jul-29-21 10:00AM
Jul-21-21 04:25AM
Jul-14-21 07:19AM
May-29-21 04:11PM
May-13-21 08:00AM
May-10-21 08:00AM
Apr-08-21 09:59AM
Mar-31-21 09:00AM
Mar-18-21 10:20PM
Mar-16-21 04:16PM
Mar-01-21 03:00PM
Feb-17-21 04:43PM
Feb-05-21 08:00AM
Feb-03-21 08:02AM
Dec-29-20 08:47AM
Dec-16-20 02:16PM
Nov-27-20 03:14AM
Nov-18-20 08:00AM
Nov-09-20 07:55AM
Nov-06-20 08:00AM
Oct-28-20 04:36PM
02:25PM
12:41PM
Oct-27-20 09:15PM
White Mountains Insurance Group Ltd. engages in the acquisition of businesses and assets in the insurance, financial services, and related sectors. It operates through the following segments: HG Global/BAM, Ark/MW Outrigger, Kudu, and Other Operations. The HG Global/BAM segment refers to White Mountains' investment in HG Global Limited, and the consolidated results of Build America Mutual Assurance Company (BAM). The Ark/WM Outrigger segment consists of Ark Insurance Holdings Limited and its subsidiaries. The Kudu segment provides capital solutions for boutique asset and wealth managers for various purposes including generational ownership transfers, management buyouts, acquisition and growth finance, and legacy partner liquidity. The Other Operations segment focuses on its wholly-owned subsidiary, WM Capital, other intermediate holding companies, investment management subsidiary, White Mountains Advisors LLC, as well as certain consolidated and unconsolidated private capital and other investments. The company was founded in 1980 and is headquartered in Hanover, NH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hicks Weston M Director Nov 17 '23 Buy 1480.56 1,000 1,480,557 2,306 Nov 20 08:58 AM WHITE MOUNTAINS INSURANCE GROU Director Jun 30 '23 Buy 10.00 5,916,816 59,168,160 22,856,814 Jun 30 08:13 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite